Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds.

Treatment with compound 4aa also trended toward decreasing IL-8 release (116.8 pg/mL), but this effect did not reach statistical significance ( p = 0.102).

also in 111,027 other papers